PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? | Semantic Scholar
Decision tree for managing PI-RADS 3 lesions in African American men... | Download Scientific Diagram
Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions | Scientific Reports
The Radiology Assistant : Prostate Cancer - PI-RADS v2
A Comparison of Image-Guided Targeted Prostate Biopsy Outcomes by PI-RADS® Score and Ethnicity in a Diverse, Multiethnic Population | Journal of Urology
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology
The basics of PI-RADS scoring and how AI can help
Cancer detection by PI-RADS score and overall | Download Scientific Diagram
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect
Frontiers | Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology
JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
The Radiology Assistant : Prostate Cancer - PI-RADS v2
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology
Prostate Imaging-Reporting and Data System (PI-RADS) | Radiology Reference Article | Radiopaedia.org
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology
Diagnostics | Free Full-Text | Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with
Gallium 68 PSMA-11 PET/CT Imaging in Patients with PI-RADS 3 | Journal of Nuclear Medicine
The basics of PI-RADS scoring and how AI can help
In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? | Egyptian Journal of Radiology and Nuclear Medicine | Full Text
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology
JCM | Free Full-Text | New Biopsy Techniques and Imaging Features of Transrectal Ultrasound for Targeting PI-RADS 4 and 5 Lesions
Analysis of PI-RADS 4 cases_ Management recommendations for negatively biopsied patients
